Medicare Enrolled
Dr. Sameh Sayfo
Internal Medicine · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sayfo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sayfo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sayfo
Dr. Sameh Sayfo is an internal medicine specialist in Plano, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sayfo performed 5,113 Medicare services across 1,940 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sayfo received a total of $744,902 from 53 pharmaceutical and/or device companies across 963 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sayfo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 6% volume in TX
$744,902 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,113
Medicare services
Top 6% in TX for internal medicine
1,940
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~301 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 2,900 | $0 | $3 |
| Electrocardiogram (EKG), 12-lead | 356 | $10 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 318 | $9 | $128 |
| Office visit, established patient (30-39 min) | 301 | $85 | $238 |
| Cardiac catheterization | 120 | $179 | $1,035 |
| Ultrasonic guidance for blood vessel access | 105 | $11 | $48 |
| Hospital follow-up visit, moderate complexity | 105 | $59 | $186 |
| Coronary stent placement | 100 | $386 | $2,063 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 87 | $70 | $333 |
| Blood draw (venipuncture) | 81 | $8 | $17 |
| EKG interpretation and report | 62 | $5 | $30 |
| Initial hospital admission, high complexity | 54 | $132 | $517 |
| Office visit, established patient, complex (40-54 min) | 51 | $137 | $335 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 49 | $66 | $1,220 |
| New patient office visit, complex (60-74 min) | 44 | $152 | $409 |
| New patient office visit (45-59 min) | 35 | $109 | $310 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 32 | $192 | $1,175 |
| Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | 31 | $119 | $1,342 |
| Review by radiologist of both arms or legs arteries image | 27 | $70 | $326 |
| Other cardiovascular service or procedure | 25 | $46 | $1,000 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $83 | $301 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 19 | $56 | $194 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $238 | $1,315 |
| Insertion of tube into vena cava | 17 | $69 | $694 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 17 | $53 | $553 |
| Removal of plaque in arteries of leg | 16 | $373 | $11,780 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 15 | $123 | $1,581 |
| Balloon dilation of artery of leg | 13 | $286 | $3,707 |
| Review by radiologist of arm or leg artery image | 13 | $63 | $290 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 12 | $278 | $1,613 |
| Insertion of stent in groin artery, initial vessel | 12 | $304 | $4,572 |
| Review by radiologist of abdominal aorta image | 12 | $51 | $237 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 12 | $5 | $48 |
| Primary removal and dissolving of blood clot from artery or artery graft using fluoroscopic guidance, initial vessel | 11 | $382 | $2,689 |
| Review by radiologist of major lower body vein image | 11 | $40 | $391 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $18 | $130 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
60.1% medium
34.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$744,902
Total received (2018-2024)
Avg $106,415/year across 7 years
Top 0% in TX for internal medicine
53
Companies
963
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$459,509 (61.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$233,512 (31.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$51,881 (7.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$321,898
2023
$227,109
2022
$135,671
2021
$47,827
2020
$8,606
2019
$2,883
2018
$908
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$153,342
Penumbra, Inc.
$118,716
Terumo Medical Corporation
$113,058
Inari Medical, Inc.
$109,959
Shockwave Medical, Inc
$69,081
Medtronic, Inc.
$48,125
Philips North America LLC
$38,907
Imperative Care, Inc
$36,180
Boston Scientific Corporation
$23,119
AngioDynamics, Inc.
$13,046
Philips Electronics North America Corporation
$6,312
Bolton Medical Inc
$2,991
Surmodics, Inc.
$2,211
Abbott Laboratories
$1,290
Silk Road Medical, Inc.
$900
Endologix LLC
$873
BOSTON SCIENTIFIC CORPORATION
$831
Medtronic Vascular, Inc.
$686
Cagent Vascular INC
$581
Novartis Pharmaceuticals Corporation
$576
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$507
ABIOMED
$495
Endovascular Engineering Inc.
$420
CORDIS US CORP.
$374
Recor Medical Inc
$319
Amgen Inc.
$186
HeartFlow, Inc.
$172
Veryan Medical Incorporated
$172
Janssen Pharmaceuticals, Inc
$161
TRUVIC MEDICAL, INC.
$137
Gilead Sciences, Inc.
$123
Regeneron Healthcare Solutions, Inc.
$114
Contego Medical, Inc
$106
Novo Nordisk Inc
$105
Amarin Pharma Inc.
$72
E.R. Squibb & Sons, L.L.C.
$70
W. L. Gore & Associates, Inc.
$67
Impulse Dynamics (USA) Inc.
$62
Astellas Pharma US Inc
$57
EKOS Corporation
$50
Esperion Therapeutics, Inc.
$46
Kiniksa Pharmaceuticals International, plc
$43
Merck Sharp & Dohme LLC
$41
Lundbeck LLC
$35
Chiesi USA, Inc.
$35
Alnylam Pharmaceuticals Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$24
Janssen Scientific Affairs, LLC
$20
SANOFI-AVENTIS U.S. LLC
$18
Kiniksa Pharmaceuticals, Ltd.
$17
Teleflex LLC
$17
Merck Sharp & Dohme Corporation
$14
Itamar Medical Inc
$13
Top 3 companies account for 51.7% of total payments
Associated products mentioned in payments ›
(5028) IGT Devices Systems Undivided · (5044) MCOT · (6342) Intrasight Integrated · (6536) Phoenix · (6554) Periph Vasc Undiv · (6554) Peripheral Vascular Undivided · (6575) Coronary Undivided · (6585) Omniwire · (7881) US Und · (8306) Azurion 7 B20 · (8334) IGT D Peripheral · (9260) QC · (9281) Turbo Elite · (9520) IGT Devices Und · (9520) IGT Devices Undivided · (BH4) IGT Devices Undivided · (P84) IGT Devices Systems · ABRE · ACCULINK · ALPHAVAC · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · ANGIOGUARD · ANGIOJET · ANGIOVAC · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Abre · Arcalyst · BioMimics · CAMZYOS · CARDENE · CLEVIPREX · CONCERTOTM · CROSSBOSS · CT THROMBECTOMY SYSTEM KIT · Chocolate PTA Balloon · Corlanor · EKOSONIC · ELLIPSYS VASCULAR ACCESS SYSTEM · ELUVIA · ENDOCROSS Device · ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · ESPRIT · EkoSonic · FFRct · FLOWTRIEVER CATHETER · FlowTriever · GENERAL VASCULAR INTERVENTION · GENERAL STENTS · GENERAL VASCULAR ACCESS · GENERAL - THERAPIES · GLIDESHEATH SLENDER · GLIDEWIRE · GORE VIABAHN Endoprosthesis with Heparin · General - Vascular Intervention · HAWKONE · HEARTRAIL · HI-TORQUE COMMAND · HawkOne · HeartMate 3 Left Ventricular Dev · Helo Thrombectomy System · IGT D Coronary · IN.PACT ADMIRAL · IN.PACT Admiral · INFINITI · INVEGA SUSTENNA · Impella · Indigo System · JETI PERIPHERAL CATHETER · LEQVIO · LEXISCAN · Lexiscan · LifeVest · METACROSS OTW · MITRACLIP · MULTAQ · MVP · MYNX CONTROL · Mitra Clip system · NAVICROSS · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · OPTIMIZER · OPTIS · Optis Coronary Imaging System · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRECISE PRO RX · PRODIGY CATHETER · PRODIGY TWIST · Penumbra System · Pounce Thrombectomy System · Pounce Venous Thrombectomy System · R2P MISAGO · RUBY Coil · Repatha · Resolute · Rybelsus · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPHONY CATHETER · SYMPLICITY G3 · Serrantor · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher · Sublime 014 Rx PTA Balloon Dilatation Catheter · TR BAND · TREO ABDOMINAL STENT-GRAFT SYSTEM · TURBOHAWK · TURNPIKE · Torus Stent Graft System · VERQUVO · VIATORR Endoprosthesis · Vascepa · Vascular Lithotripsy · Verquvo · WATCHMAN · WatchPATONE · XACT · XARELTO · ZOOM 88-T LARGE DISTAL PLATFORM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.
Equivalent to $14,569 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
2,017
Per 100K population
180.6
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sayfo is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), with speaking/promotional industry engagement in the top 0% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sayfo experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Sayfo performed 2,900 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sayfo receive payments from pharmaceutical companies?
Yes. Dr. Sayfo received a total of $744,902 from 53 companies across 963 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sayfo's costs compare to other internal medicine physicians in Plano?
Dr. Sayfo's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sayfo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Plano
Browse internal medicine physicians in Plano ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
ShockWave Medical, Inc Payments to Doctors
See all physicians who received payments from ShockWave Medical, Inc.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc.
By company
Terumo Medical Corporation Payments to Doctors
See all physicians who received payments from Terumo Medical Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology